University of Iowa Holden Comprehensive Cancer Center and Mayo Clinic have received a five-year, $12.4 million grant renewal from the National Cancer Institute to continue the Specialized Program of Research Excellence (SPORE) for lymphoma research. The renewal was based on a highly competitive process of peer review conducted by cancer researchers from across the country. The research collaboration focuses on developing new approaches to the prevention, detection and treatment of lymphoma. First funded in 2002 and competitively renewed three times, it’s the nation’s longest-standing lymphoma SPORE and has now received more than $46 million from the NCI.